tiprankstipranks
Infant Bacterial Therapeutics AB (DE:9IB)
FRANKFURT:9IB
Germany Market
9IB
Infant Bacterial Therapeutics AB
RESEARCH TOOLSreports

Infant Bacterial Therapeutics AB (9IB) Financial Statements

4 Followers

Infant Bacterial Therapeutics AB Financial Overview

Infant Bacterial Therapeutics AB's market cap is currently €78.60M. The company's EPS TTM is €-6.09; its P/E ratio is -10.67; Infant Bacterial Therapeutics AB is scheduled to report earnings on August 26, 2026, and the estimated EPS forecast is €-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 0.00kr 4.00Kkr 77.00Kkr 12.00Kkr 0.00
Gross Profitkr 0.00kr 4.00Kkr 77.00Kkr 12.00Kkr 0.00
Operating Incomekr -61.95Mkr -139.90Mkr -134.62Mkr -65.81Mkr -44.58M
EBITDAkr -68.18Mkr -136.91Mkr 11.55Mkr -64.34Mkr -43.76M
Net Incomekr -65.17Mkr -136.91Mkr -123.07Mkr -65.45Mkr -44.99M
Balance Sheet
Cash & Short-Term Investmentskr 144.01Mkr 223.39Mkr 329.06Mkr 335.84Mkr 386.75M
Total Assetskr 161.75Mkr 239.57Mkr 351.33Mkr 349.62Mkr 408.48M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -144.01Mkr -223.39Mkr -329.06Mkr -335.84Mkr -386.75M
Total Liabilitieskr 56.42Mkr 69.30Mkr 46.18Mkr 17.91Mkr 13.22M
Stockholders' Equitykr 105.33Mkr 170.26Mkr 305.15Mkr 331.71Mkr 395.25M
Cash Flow
Free Cash Flowkr -72.34Mkr -113.13Mkr -101.22Mkr -85.80Mkr -55.62M
Operating Cash Flowkr -72.34Mkr -113.13Mkr -101.22Mkr -85.80Mkr -55.62M
Investing Cash Flowkr 0.00kr 0.00kr -4.15Mkr -1.00Kkr 0.00
Financing Cash Flowkr 0.00kr 2.01Mkr 96.52Mkr 1.88Mkr 91.00K
Currency in SEK

Infant Bacterial Therapeutics AB Earnings and Revenue History

Income Statement >

Infant Bacterial Therapeutics AB Debt to Assets

Balance Sheet >

Infant Bacterial Therapeutics AB Cash Flow

Cash Flow >

Infant Bacterial Therapeutics AB Forecast EPS vs Actual EPS

Earnings >